• 1
    Wakitani S, Goto T, Pineda SJ, et al. 1994. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg 76-A: 579592.
  • 2
    Grande DA, Southerland SS, Manji R, et al. 1995. Repair of articular cartilage defects using mesenchymal stem cells. Tissue Eng 1: 345353.
  • 3
    Lazarus HM, Haynesworth SE, Gerson SL, et al. 1995. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 16: 557564.
  • 4
    Bruder SP, Fink DJ, Caplan AI. 1994. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. J Cell Biochem 56: 282294.
  • 5
    Bruder SP, Jaiswal N, Ricalton NS, et al. 1998. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop 355S: S247S256.
  • 6
    Smith RK, Korda M, Blunn GW, et al. 2003. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment. Equine Vet J 35: 99102.
  • 7
    Smith RK, Webbon PM. 2005. Harnessing the stem cell for the treatment of tendon injuries: heralding a new dawn? Br J Sports Med 39: 582584.
  • 8
    Crovace A, Lacitignola L, De SR, et al. 2007. Cell therapy for tendon repair in horses: an experimental study. Vet Res Commun 31 (Suppl 1): 281283.
  • 9
    Bradshaw R, Cavanaugh K. 1990. Isolation and characterization of growth factors. In: SpornM, RobertsA, editors. Peptide growth factors and their receptors 1. 1st ed. New York: Springer-Verlag. p 1765.
  • 10
    Rechler MM, Nissley SP. 1990. Insulin-like growth factors. In: SpornMB, RobertsAB, editors. Peptide growth factors and their receptors. New York: Springer Verlag.
  • 11
    Sporn M, Roberts A. 1990. The multifunctional nature of peptide growth factors. In: SpornM, RobertsA, editors. Peptide growth factors and their receptors 1. 1st ed. New York: Springer-Verlag. p 315.
  • 12
    Abrahamsson S-O, Lundborg G, Lohmander LS. 1991. Long-term explant culture of rabbit flexor tendon: Effects of recombinant human insulin-like growth factor-I and serum on matrix metabolism. J Orthop Res 9: 503515.
  • 13
    Lee J, Green MH, Amiel D. 1994. The study of growth factors and their synergy on cell outgrowth from rabbit anterior cruciate and medial collateral ligament explants. Trans 40th Ann Mtg ORS; 19: 60.
  • 14
    Tsuzaki M, Brigman BE, Xiao H, et al. 1994. IGF-I and TGF-B drive tendon cell DNA synthesis. Trans 40th Ann Mtg ORS; 19: 18.
  • 15
    Abrahamsson S-O, Lundborg G, Lohmander LS. 1991. Recombinant human insulin-like growth factor-I stimulates in vitro matrix synthesis and cell proliferation in rabbit flexor tendon. J Orthop Res 9: 495502.
  • 16
    Hansson H-A, Dahlin LB, Lundborg G, et al. 1988. Transiently increased insulin-like growth factor I immunoreactivity in tendons after vibration trauma. Scand J Plast Reconstr Surg Hand Surg 22: 16.
  • 17
    Banes AJ, Tsuzaki M, Hu P, et al. 1995. PDGF-BB, IGF-I and mechanical load stimulate DNA synthesis in avian tendon fibroblasts in vitro. J Biomech 28: 15051513.
  • 18
    DesRosiers EA, Yahia L, Rivard C-H. 1996. Proliferative and matrix synthesis response of canine anterior cruciate ligament fibroblasts submitted to combined growth factors. J Orthop Res 14: 200208.
  • 19
    Abrahamsson SO, Lohmander S. 1996. Differential effects of insulin-like growth factor-I on matrix and DNA synthesis in various regions and types of rabbit tendons. J Orthop Res 14: 370376.
  • 20
    Dahlgren LA, van der Meulen MC, Bertram JE, et al. 2002. Insulin-like growth factor-I improves cellular and molecular aspects of healing in a collagenase-induced model of flexor tendinitis. J Orthop Res 20: 910919.
  • 21
    Wilke MM, Nydam D, Nixon AJ. 2007. Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 25: 913925.
  • 22
    Nixon AJ, Dahlgren LA, Haupt JL, et al. 2008. Effect of adipose-derived nucleated cell fractions on tendon repair in horses with collagenase-induced tendinitis. Am J Vet Res 69: 928937.
  • 23
    Haupt JL, Nixon AJ. 2007. Gene enhanced mesenchymal stem cells for the treatment of tendonitis. Trans 52nd Ann Mtg ORS.
  • 24
    Schnabel LV, Mohammed HO, Miller BJ, et al. 2007. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res 25: 230240.
  • 25
    Dahlgren LA, Mohammed HO, Nixon AJ. 2005. Temporal expression of growth factors and matrix molecules in healing tendon lesions. J Orthop Res 23: 8492.
  • 26
    Sodersten F, Ekman S, Eloranta ML, et al. 2005. Ultrastructural immunolocalization of cartilage oligomeric matrix protein (COMP) in relation to collagen fibrils in the equine tendon. Matrix Biol 24: 376385.
  • 27
    Smith RK, Gerard M, Dowling B, et al. 2002. Correlation of cartilage oligomeric matrix protein (COMP) levels in equine tendon with mechanical properties: a proposed role for COMP in determining function-specific mechanical characteristics of locomotor tendons. Equine Vet J Suppl 241244.
  • 28
    Smith RKW, Zunino L, Webbon PM, et al. 1997. The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age and load. Matrix Biol 16: 255.
  • 29
    Oshiro W, Lou J, Xing X, et al. 2003. Flexor tendon healing in the rat: a histologic and gene expression study. J Hand Surg Am 28: 814823.
  • 30
    Jones GC, Corps AN, Pennington CJ, et al. 2006. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human achilles tendon. Arthritis Rheum 54: 832842.
  • 31
    Alfredson H, Lorentzon M, Backman S, et al. 2003. cDNA-arrays and real-time quantitative PCR techniques in the investigation of chronic Achilles tendinosis. J Orthop Res 21: 970975.
  • 32
    Fortier LA, Schnabel LV, Mohammed HO, et al. 2007. Assessment of cartilage degradation effects of matrix metalloproteinase-13 in equine cartilage cocultured with synoviocytes. Am J Vet Res 68: 379384.
  • 33
    Goodrich LR, Chen CT, Hidaka C, et al. 2007. Catabolic cytokine profiles of cartilage adjacent to chondral defects explain the biomechanically inferior tissue. Trans 52nd Ann Mtg ORS 31: 46.
  • 34
    Dahlgren LA, Brower-Toland BD, Nixon AJ. 2005. Cloning and expression of type III collagen in normal and injured tendons of horses. Am J Vet Res 66: 266270.
  • 35
    Goodrich LR, Hidaka C, Robbins PD, et al. 2007. Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg 89-B: 672685.
  • 36
    Kim Y-J, Sah RLY, Doong J-YH, et al. 1988. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal Biochem 174: 168176.
  • 37
    Farndale RW, Buttle DJ, Barrett AJ. 1986. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochem Biophys Acta 883: 173177.
  • 38
    Maffulli N, Longo UG, Franceschi F, et al. 2008. Movin and Bonar scores assess the same characteristics of tendon histology. Clin Orthop Relat Res 466: 16051611.
  • 39
    Cook JL, Feller JA, Bonar SF, Khan KM. 2004. Abnormal tenocyte morphology is more prevalent than collagen disruption in asymptomatic athletes' patellar tendons. J Orthop Res 22: 334338.
  • 40
    Taylor SE, Smith RK, Clegg PD. 2007. Mesenchymal stem cell therapy in equine musculoskeletal disease: scientific fact or clinical fiction? Equine Vet J 39: 172180.
  • 41
    Foland J, Trotter GW, Powers BE, et al. 1992. Effect of sodium hyaluronate in collagenase-induced superficial digital flexor tedinitis in horses. Am J Vet Res 54: 23712376.
  • 42
    Gaughan EM, Gift LJ, De Bowes RM, et al. 1995. The influence of sequential intratendinous sodium hyaluronate on tendon healing in horses. Vet Comp Orthop Traum 8: 4045.
  • 43
    Gift LJ, Gaughan EM, DeBowes RM, et al. 1992. The influence of intratendinous sodium hyaluronate on tendon healing in horses. Vet Comp Orthop Traumatol 4: 151157.
  • 44
    Tkach LV, Nguyen V-DN, Coutts RD, McFadden PR. 1993. A model of experimentally induced tendinosis. Trans 39th Ann Mtg ORS 18: 366366.
  • 45
    Soslowsky LJ, Carpenter JE, DeBano CM, Banerji I, et al. 1996. Development and use of an animal model for investigations on rotator cuff disease. J Shoulder Elbow Surg 5: 383392.
  • 46
    Spurlock GH, Spurlock SL, Parker GA. 1988. Ultrasonographic, gross, and histologic evaluation of a tendinitis disease model in the horse. Vet Rad 30: 184188.
  • 47
    Williams IF, McCullagh GD, Goodship AE, et al. 1984. Studies on the pathogenesis of equine tendinitis following collagenase injury. Res Vet Sci 36: 326338.
  • 48
    Williams IF, McCullagh KG, Silver IA. 1984. Distribution of types I and III collagen and fibronectin in the healing equine tendon. Connect Tissue Res 12: 211227.
  • 49
    Silver IA, Brown PN, Goodship AE, et al. 1983. A clinical and experimental study of tendon injury and treatment in the horse. Equine Vet J Suppl 135.
  • 50
    Guest DJ, Smith MR, Allen WR. 2008. Monitoring the fate of autologous and allogeneic mesenchymal progenitor cells injected into the superficial digital flexor tendon of horses: preliminary study. Equine vet J 40: 178181.
  • 51
    Abrahamsson S-O. 1997. Similar effects of recombinant human insulin-like growth factor-I and II on cellular activities in flexor tendons of young rabbits: experimental studies in vitro. J Orthop Res 15: 256262.
  • 52
    Murphy DJ, Nixon AJ. 1997. Biochemical and site-specific effects of insulin-like growth factor I on intrinsic tenocyte activity in equine flexor tendons. Am J Vet Res 58: 103109.
  • 53
    Goodrich LR, Hidaka C, Strassheim ML, et al. 2004. Enhanced survival of chondrocytes over-expressing insulin-like growth factor I in equine cartilage repair. Mol Ther 9: S340.
  • 54
    Fortier LA, Smith RK. 2007. Evidence for stem cells in cartilage regeneration. AAEP 53: 329334.